Status:
UNKNOWN
Pupillometry-guided Remifentanil Infusion Versus Conventional Administration in Children
Lead Sponsor:
Seoul National University Hospital
Conditions:
Opioid Use
Eligibility:
All Genders
3-12 years
Phase:
NA
Brief Summary
Our study aims to compare the total intravenous dose of remifentanil per anesthesia hour and body weight in two groups of pediatric surgical patients - an interventional group with remifentanil infusi...
Detailed Description
comparison of total used opioid
Eligibility Criteria
Inclusion
- Pediatric patients who are at 3 to 6 years of age, scheduled to undergo elective surgery with estimated time of operation 2 hours or longer, under general anesthesia
- American Society of Anesthesiologists physical status classification (ASA class) I - II
- Patient and his/her parents are willing to participate after explanation of the purpose, materials, methods, possible risks and benefits of the research
Exclusion
- History of hypersensitivity/allergic reaction to the drugs which are used in general anesthesia
- Preoperative use of analgesics, antipsychotics and/or antiepileptics
- Mental retardation
- Medications related to hindrance of autonomic nerve system activity, e. g., beta blockers
- Underlying ophthalmic diseases
Key Trial Info
Start Date :
December 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 18 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03749811
Start Date
December 4 2018
End Date
November 18 2021
Last Update
March 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea